Phase I Clinical Trial of FLAG-003 for the Treatment of Glioma

NCBiotech Grants & Loans

See the full listing of all NCBiotech grants and loans awarded since July 2012.

Organization
FLAG Therapeutics Inc
Award Date
Award Amount
500,000
Program Name
Strategic Growth Loan
Program Category
Business Financing
Principal Investigator
Frank Sorgi
Fiscal Year
2018
Region
Research Triangle
Project Description: FLAG Therapeutics is an early stage oncology company with a late stage pre-clinical novel small molecule lead for the treatment of primary brain tumors (gliomas). The project will support IND filing and completion of their Phase I safety study.
scroll back to top of page